ICIS News – Activist premise on Dow spin false (January 27, 2014)
Young & Partners disagrees with shareholder activist premise about Dow Chemical
Pharma and Biotech Financial Trends: Every Which Way (Young & Partners article written for the Pharma Exec Dec 2013 Issue)
Article summarizing the latest business, M&A and financial developments in Biopharma
Activist Investors Target Chemicals (Young & Partners article in ICIS Oct. 1 – 13, 2013)
Perspectives on what these activists try to do and how should management react?
Chemical M&A Rebound Continues (Young & Partners article in ICIS Sept 30 – Oct 6, 2013)
Young & Partners describes the factors driving the ongoing rebound
Chemical M&A Market Revives (Young & Partners article in ICIS July 15 – 28, 2013)
Young & Partners article about what is driving the current chemical M&A revival
Sunny Outlook for Chemical Financing (Young & Partners article in ICIS Feb. 25 – March 3, 2013)
Overall chemical industry's debt and equity financing activity has been positive
Banker – M&A down in 2012, But Improving (Chemical Week Feb. 18, 2013 Issue)
Young & Partners' view of chemical industry M&A in 2012 and outlook for 2013
Chemical M&A Market Down But Not Out (Young & Partners article in ICIS Feb 11-17, 2013)
Unique insights about what happened last year and the positive outlook ahead
Breaking Waves – Turbulent Times for the Biopharma Business (Young & Partners Article in Pharma Exec Nov 2012 Issue)
Turbulence and Uncertainties Driving Pharma and Biotech M&A and Financial Environment
Banker – Big uptick in chemical debt financing (Chemical Week October 2, 2012)
Peter Young comments on the strength of chemical industry debt and equity financing activity